Sulopenem-Etzadroxil/Probenecid
IT001-301
Phase 3 small_molecule completed
Quick answer
Sulopenem-Etzadroxil/Probenecid for Uncomplicated Urinary Tract Infections is a Phase 3 program (small_molecule) at Iterum Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iterum Therapeutics plc
- Indication
- Uncomplicated Urinary Tract Infections
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed